Two Biosensors for the Determination of Interleukin-6 in Blood Plasma by Array SPRi

Interleukin-6 (IL-6) is a biomarker of inflammation, the advanced stage of COVID-19, and several cancers, including ovarian cancer. Two biosensors for the determination of IL-6 in blood plasma by array SPRi have been developed. One of these biosensors consists of the mouse monoclonal anti-IL-6 antib...

Full description

Bibliographic Details
Published in:Biosensors
Main Authors: Beata Szymanska, Zenon Lukaszewski, Lukasz Oldak, Beata Zelazowska-Rutkowska, Kinga Hermanowicz-Szamatowicz, Ewa Gorodkiewicz
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Subjects:
interleukin-6
array SPRi
cancer biomarkers
ovarian cancer
blood plasma
Online Access:https://www.mdpi.com/2079-6374/12/6/412

Internet

https://www.mdpi.com/2079-6374/12/6/412

Similar Items